Human vaccine against Leptospirosis
Project 99
Problem to be solved
- Zoonosis of worldwide range
- Severe public health problem
- Controlling outbreaks
- Absence of the human vaccine in Brazil
Proposed innovation
- Safe and effective vaccine
- Use of recombinant antigens
- Vaccine coverage for different pathogenic serovars
Differential
- Low reactogenicity
- Long-lasting protection
Development status
Laboratorial prototype
Intellectual property status
BRPI0505529-6 (corresponding application filed in Europe and Canada)
What we want
Partnership
Coordinator
Marco Alberto Medeiros / Biomanguinhos
Contact
Gestec/VPPIS – phone: 21 3882 9099/ 3882 9120 or portfolio@fiocruz.br